Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-02-25 @ 4:15 AM
Study NCT ID:
NCT03739606
Status:
WITHDRAWN
Last Update Posted:
2020-12-17
First Post:
2018-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer
Sponsor:
Organization: